New Onset of Neuro-Sjögren's Syndrome Nine Months After the Third COVID-19 Vaccine Dose: A Case Report

被引:2
|
作者
Bakhsh, Raja [1 ]
Dairi, Khaled [1 ]
Almadabgy, Elaf [1 ]
Albiladi, Amani [1 ]
Gamal, Lamyaa [1 ]
Almatrafi, Duaa [1 ]
Alshariff, Fatmah [2 ]
Alsefri, Afnan [2 ]
机构
[1] King Faisal Hosp, Minist Hlth, Internal Med, Mecca, Saudi Arabia
[2] Ibn Sina Coll, Internal Med, Jeddah, Saudi Arabia
关键词
neuro-sj & ouml; gren's syndrome; vaccination; autoimmunity; sars-cov-2; central nervous system;
D O I
10.7759/cureus.69562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sj & ouml;gren's syndrome (SS) is an autoimmune chronic inflammatory disease causing peripheral nerve system and central nervous system issues. It results from lymphocytic infiltrates in exocrine glands, coexists with rheumatoid arthritis, and manifests independently. The COVID-19 vaccine has been linked to increased autoimmune diseases and rheumatological flare-ups, possibly due to its use of adjuvants and molecular mimicry, particularly those containing aluminum. Additionally, SS-like manifestations have been reported after the infection or vaccination, potentially leading to long-term salivary secretory dysfunction. Multiple studies have suggested the presence of a special relationship between COVID-19 vaccination/infection and the emergence of autoimmune syndromes as a negative side effect of the vaccine or direct complication from infection. The time frame for the appearance of the symptoms after vaccination or disease is not well established. Some studies suggested increased risk shortly after vaccination, while others suggested a longterm association. In this case, report, and review article, we discuss the presence of a possible association with the emergence of neuro-SS in a young lady nine months after she received her third dose of COVID-19 vaccination. Furthermore, we reviewed studies highlighting the special link and relationship between the COVID-19 vaccine/infection and SS.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] COVID-19 vaccine-associated myocarditis in an adolescent after the third vaccine dose. Case report with follow-up
    Puchalski, Mateusz
    Barczuk-Falecka, Marzena
    Werner, Bozena
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2023, 19 (04): : 431 - 436
  • [2] A Case Report: Long Post-COVID Vaccination Syndrome During the Eleven Months After the Third Moderna Dose
    Finsterer, Josef
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [3] Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report
    Lemoine, Chantal
    Padilla, Cristina
    Krampe, Noah
    Doerfler, Sean
    Morgenlander, Adam
    Thiel, Brent
    Aggarwal, Rohit
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1597 - 1601
  • [4] Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report
    Aouintia, Imen
    Daly, Wiem
    Lakhoua, Ghozlane
    Kaabi, Widd
    Charfi, Ons
    Debbeche, Sana
    Kastalli, Sarrah
    Zaiem, Ahmed
    El Aidli, Sihem
    CURRENT DRUG SAFETY, 2024, 19 (02) : 306 - 308
  • [5] Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis
    van der Togt, Celeste J. T.
    Ten Cate, David F.
    van den Bemt, Bart J. F.
    Rahamat-Langendoen, Janette
    den Broeder, Nathan
    den Broeder, Alfons A.
    RHEUMATOLOGY, 2023, 62 (04) : 1627 - 1630
  • [6] Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report
    Chantal Lemoine
    Cristina Padilla
    Noah Krampe
    Sean Doerfler
    Adam Morgenlander
    Brent Thiel
    Rohit Aggarwal
    Clinical Rheumatology, 2022, 41 : 1597 - 1601
  • [7] Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report
    Khalayli, Naram
    Omar, Abdullah
    Kudsi, Mayssoun
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [8] Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report
    Naram Khalayli
    Abdullah Omar
    Mayssoun Kudsi
    Journal of Medical Case Reports, 17
  • [9] New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report
    Shinya Nakatani
    Katsuhito Mori
    Fumiyuki Morioka
    Chika Hirata
    Akihiro Tsuda
    Hideki Uedono
    Eiji Ishimura
    Daisuke Tsuruta
    Masanori Emoto
    CEN Case Reports, 2022, 11 : 358 - 362
  • [10] New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination: A case report
    Kobayashi, Takaaki
    Yakou, Fumiyoshi
    Saburi, Masuo
    Hirose, Ai
    Akaoka, Hiroaki
    Hirota, Yusuke
    Yunaiyama, Daisuke
    Asahi, Nobuteru
    Ohno, Atsushi
    Matsushita, Takaya
    CLINICAL CASE REPORTS, 2022, 10 (10):